Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Netflix (NFLX) Stock Rises on High Expectations for Ad Sales

With Netflix reeling this year, many analysts see its pivot to ad-tier subs as positive for NFLX stock though not all are convinced.

7 Value Stocks That Are Too Cheap to Ignore

With market and economic forces eschewing growth-focused companies, now may be the time to consider cheap value stocks to buy.

Levi Strauss (LEVI) Stock Sinks 10% on Reduced Guidance

Although Levi Strauss admitted to macro pressures forcing a full-year downgrade, LEVI stock might perform better than its peers.

CVS Health (CVS) Stock Falls 10% on Health Insurance Plan Downgrade

CVS Health received an insurance-related downgrade from Medicare, sending CVS stock into the dumps despite management’s reassurances.

7 Small-Cap Stocks That Are Too Cheap to Ignore

Although this avenue is best reserved for contrarian speculators, some exciting opportunities exist among cheap small-cap stocks to buy.